PATENT CLAIM ANALYSIS

Application Number: 15781303
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "210160"]

Abstract:
The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted monocyclic heteroaryl compounds of Formula (I), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.

Claim (Index 17):
A use of the compound of  claim 1 , in admixture with one or more pharmaceutically acceptable excipient(s) in a pharmaceutical composition for treating or ameliorating HD in a subject in need thereof, comprising administering an effective amount of the pharmaceutical composition to the subject.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 94.0
- Lexical Diversity: 2.23529
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14160180', '14242282', '13812366', '13653192', '14363051']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7525905274532483
- 35 USC 102 Novelty (BERT): 0.5310393618501302
- Combined Prediction Score: 0.7304354108929365
- Mean Citation Score: 296.341898
- Max Citation Score: 358.8583
- Similarity Product: 254.71345214342475

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test